Ligand · 052
052 · N-cyclopropyl-2-methyl-4-(7-{[2-(morpholin-4-yl)ethyl]amino}-5-phenoxypyrazolo[1,5-a]pyrimidin-3-yl)benzamide
052, N-cyclopropyl-2-methyl-4-(7-{[2-(morpholin-4-yl)ethyl]amino}-5-phenoxypyrazolo[1,5-a]pyrimidin-3-yl)benzamide (C29 H32 N6 O3, 512.6 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site…
- Component
- 052
- Formula
- C29 H32 N6 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
052 in 2 structures; the first of them:
- 4ZEG · Crystal structure of TTK kinase domain in complex with a pyrazolopyrimidine inhibitor · 052 A809 · binds LYS529, ILE531, GLY532, VAL539, GLN541, ALA551, LYS553, GLU571 and 17 more
- 4ZEG · Crystal structure of ttk kinase domain in complex with a pyrazolopyrimidine inhibitor · 052 A809 · binds LYS529, ILE531, GLY532, VAL539, GLN541, ALA551, LYS553, GLU571 and 17 more
Residues it binds most
ILE 2, MET 2, ALA 2, ASP 2, GLN 2, GLU 2, GLY 2, LEU 2, LYS 2, ASN 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.